• M.D., University of Montreal, 1988

About Dr. Galipeau:

Dr. Galipeau is a Professor of Hematology and Medical Oncology, Pediatrics & Medicine, Emory School of Medicine and is Co-Director of the Winship Cancer Institute Tumor Immunology-Immunotherapy initiative as well as Director of the Emory Personalized Immunotherapy Center (EPIC) and has been named a Georgia Cancer Coalition Distinguished Cancer Scholar. Dr. Jacques Galipeau obtained his Medical Degree from the University of Montreal in 1988 and completed specialty training in internal medicine at the McGill-affiliated Jewish General Hospital. He went on to the Tufts-affiliated New England Medical Center in Boston for three years of subspecialty training in Hematology and Oncology followed by a two-year scientific fellowship in gene Therapy at St-Jude Children’s research hospital in Memphis Tennessee. In his 12 year career at McGill University starting in 1997, he initiated and developed a research program in cell and immunotherapy of catastrophic illnesses including cancer, immune and cardiovascular disease. The development of regenerative medicine and innovative cell-based therapies are on-going research and development interests pursued at Emory University since October 2009.

Research Interests:

My laboratory research is focused on cell and biological therapy for cancer and immune ailments. We are also exploring the utility of stem cells for regenerative medicine, immune modulation and for delivery of therapeutic proteins for treatment of acquired and hereditary diseases.